Open Data

"(A)t least 70 people have died, many of them by suicide, after Tamiflu-induced episodes," reports Newsweek, in an article about the popular anti-flu drug...

The US government is proposing to toughen the rules governing medical trials involving human subjects, to help ensure the trials are registered in advance...

In two posts on PLOS Blogs, Tom Jefferson of the Cochrane Acute Respiratory Infections Group in Italy reviews the European Medicines Agency’s new regulations...

The new Social Security Act, an Obamacare-inspired, Open Payments report came out September 30th. As part of the new healthcare reform policy, this federal report requires pharmaceutical and medical device companies to annually share documentation of direct payments they provided to entities such as medical practices and teaching hospitals. But before anyone gets excited and thinks there is finally a reliable and valid monitoring method to document that such payments are minimal as well as on the up and up, please note that 40% of the payment records (considered for inclusion in the 2013 Open Payments report) were not included in the $3.5 billion due to “unresolved questions” being cited.

The European Medicines Agency has announced in a press release its final policies on the open publication of data from clinical trials. Ed Silverman...

The new President-elect of the European Union Jean-Claude Juncker has removed key responsibilities relating to health and medicines from the government Commissioner in charge...

The production of modern scientific studies is fundamentally biased and most often leads to unreliable results that no one will be funded to try...

The European Medicines Agency has announced a new policy that it says will open public access to pharmaceutical companies’ medical trial data. The new...